These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 205882)

  • 21. Influence of D-penicillamine on the immune response of mice.
    Schumacher K; Maerker-Alzer G; Schaaf W
    Arzneimittelforschung; 1975 Apr; 25(4):600-3. PubMed ID: 1098678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cooperation of normal and malignant lymphoid cells in the immune response against sheep erythrocytes.
    Boranić M; Hrsak I; Marotti T; Mazuran R; Silobrcić V
    Biomedicine; 1974 Jan; 21(1):9-12. PubMed ID: 4858487
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antilymphocyte serum: methods for its preparation and measurement in vitro of its biological activity].
    Tursi A
    Haematologica; 1970 Dec; 55(12):766-73. PubMed ID: 5003116
    [No Abstract]   [Full Text] [Related]  

  • 24. Tumour immunology; escape mechanisms.
    Klein E
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):593-602. PubMed ID: 5050870
    [No Abstract]   [Full Text] [Related]  

  • 25. Thymus: an essential factor in lymphoid repopulation.
    Stutman O; Yunis EJ; Good RA
    Transplant Proc; 1969 Mar; 1(1):614-5. PubMed ID: 4400068
    [No Abstract]   [Full Text] [Related]  

  • 26. Dynamics of immunologic enhancement.
    Kaliss N
    Transplant Proc; 1970 Mar; 2(1):59-67. PubMed ID: 4940355
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of serial transplantation on the immunological-clinical correlates of BALB/cfC3H mouse mammary tumors.
    Hager JC; Miller FR; Heppner GH
    Cancer Res; 1978 Aug; 38(8):2492-500. PubMed ID: 667845
    [No Abstract]   [Full Text] [Related]  

  • 28. Destructive and nondestructive patterns of immune rejection of syngeneic intraocular tumors.
    Knisely TL; Luckenbach MW; Fischer BJ; Niederkorn JY
    J Immunol; 1987 Jun; 138(12):4515-23. PubMed ID: 3108394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation of MLC reactivity after experimental and clinical transplantation. Virus and cytophilic antibody: sources of false negatives.
    Miller J; Howard RJ; Hattler BG; Najarian JS
    Transplant Proc; 1973 Dec; 5(4):1771-4. PubMed ID: 4359724
    [No Abstract]   [Full Text] [Related]  

  • 30. Cell mediated immune reactions "in vitro". Reactivity of lymphocytes from animals sensitized to chicken erythrocytes, tuberculin or transplantation antigens.
    Chapuis B; Brunner KT
    Int Arch Allergy Appl Immunol; 1971; 40(3):321-39. PubMed ID: 5313314
    [No Abstract]   [Full Text] [Related]  

  • 31. Nonspecific stimulation and modulation of the immune response and of states of resistance by the methanol-extraction residue fraction of tubercle bacilli.
    Weiss DW
    Natl Cancer Inst Monogr; 1972 Dec; 35():157-71. PubMed ID: 4633406
    [No Abstract]   [Full Text] [Related]  

  • 32. Suppression of cell-mediated cytotoxicity by lymphocytes from tumor-bearing animals.
    Hellström I; Hellström KE; Kall MA; Nelson K; Pollack S
    Transplant Proc; 1976 Jun; 8(2):255-64. PubMed ID: 936286
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of immunological enhancement for the growth of autochthonous tumors.
    Hellström I; Hellström KE
    Transplant Proc; 1971 Mar; 3(1):721-4. PubMed ID: 4106337
    [No Abstract]   [Full Text] [Related]  

  • 34. Perspectives on oncogenesis: does immunity stimulate or inhibit neoplasia?
    Prehn RT
    J Reticuloendothel Soc; 1971 Jul; 10(1):1-16. PubMed ID: 4330591
    [No Abstract]   [Full Text] [Related]  

  • 35. Radioresistance of some biologic properties of mouse mast cells.
    Kojima S; Ovary Z
    J Immunol; 1974 Aug; 113(2):673-6. PubMed ID: 4858627
    [No Abstract]   [Full Text] [Related]  

  • 36. Mechanisms of immunologic enhancement.
    Amos DB; Cohen I; Klein WJ
    Transplant Proc; 1970 Mar; 2(1):68-75. PubMed ID: 4107294
    [No Abstract]   [Full Text] [Related]  

  • 37. Skin-graft rejection during lymphomagenesis in urethan-treated mice.
    Parmiani G
    J Natl Cancer Inst; 1971 Sep; 47(3):569-73. PubMed ID: 4945590
    [No Abstract]   [Full Text] [Related]  

  • 38. Tumor immunity and the mechanism of polyinosinic-polycytidylic acid inhibition of tumor growth.
    Kreider JW; Benjamin SA
    J Natl Cancer Inst; 1972 Nov; 49(5):1303-10. PubMed ID: 4568087
    [No Abstract]   [Full Text] [Related]  

  • 39. [Suppression of the primary response to SRBC in mice after short-term RES-"blockage" (author's transl)].
    Noltenius HW; Chahin M; Ghorra MC
    Verh Dtsch Ges Pathol; 1972; 56():385-8. PubMed ID: 4130850
    [No Abstract]   [Full Text] [Related]  

  • 40. Potentiation of cortisone-induced RES suppression in mice by vitamin K 1 .
    Pariser RJ; Munson AE; Mellette SJ
    J Reticuloendothel Soc; 1973 Apr; 13(4):319-24. PubMed ID: 4701570
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.